A 52-year-old man from Mumbai presents with a 3-month history of progressive abdominal distension, early satiety, and weight loss of 8 kg. On examination, he has hepatomegaly (liver span 16 cm) and ascites. Ultrasound abdomen shows a heterogeneous mass in the liver with features suggestive of hepatocellular carcinoma (HCC). Serum alpha-fetoprotein (AFP) is 1200 ng/mL (normal <20 ng/mL), and HBsAg is positive. What is the most appropriate interpretation of the elevated AFP in this clinical context?

Explanation

## Interpretation of Elevated AFP in HCC ### Role of AFP as a Tumor Marker **Key Point:** AFP is a glycoprotein normally produced by fetal hepatocytes and yolk sac endoderm. In HCC, malignant hepatocytes revert to fetal gene expression patterns and resume AFP synthesis. ### Diagnostic Significance **High-Yield:** AFP levels correlate with HCC diagnosis and prognosis: - **AFP >400 ng/mL** in a patient with cirrhosis + imaging findings consistent with HCC = diagnostic (AASLD criteria) - **AFP 20–400 ng/mL** requires imaging confirmation (ultrasound, CT, or MRI with arterial enhancement) - **AFP <20 ng/mL** does NOT exclude HCC (~30% of HCC patients have normal AFP) ### Clinical Utility Table | AFP Level | Clinical Context | Interpretation | | --- | --- | --- | | >400 ng/mL | Cirrhosis + imaging findings | Diagnostic of HCC | | 20–400 ng/mL | Cirrhosis + nodule | Requires imaging confirmation | | <20 ng/mL | Cirrhosis + nodule | Does NOT exclude HCC; imaging essential | | Elevated in benign disease | Chronic hepatitis, cirrhosis, pregnancy | Reduced specificity; use in combination with imaging | ### Prognostic Significance **Clinical Pearl:** Baseline AFP level and AFP kinetics (rate of rise) predict: - Tumor burden and aggressiveness - Response to treatment (falling AFP = good response) - Overall survival and recurrence risk ### Limitations **Warning:** AFP is NOT specific for HCC: - Elevated in benign cirrhosis (10–30% of cases) - Elevated in chronic hepatitis B and C - Elevated in germ cell tumors (testicular cancer, ovarian cancer) - Elevated in gastric and pancreatic cancers **Key Point:** AFP must ALWAYS be interpreted alongside imaging (ultrasound, CT, or MRI) and clinical context. Imaging is the gold standard for HCC diagnosis; AFP is a supportive marker. ### Diagnostic Algorithm for HCC ```mermaid flowchart TD A[Cirrhosis + nodule on imaging]:::outcome --> B{Size of nodule?}:::decision B -->|>20 mm| C{AFP + imaging pattern?}:::decision B -->|10-20 mm| D[Follow-up ultrasound q3-4 months]:::action C -->|Arterial enhancement + washout| E[HCC diagnosed]:::outcome C -->|AFP >400 ng/mL + imaging| F[HCC diagnosed]:::outcome C -->|Inconclusive| G[CT or MRI for confirmation]:::action G --> H{Typical HCC pattern?}:::decision H -->|Yes| I[HCC diagnosed]:::outcome H -->|No| J[Biopsy or close follow-up]:::action ``` [cite:Harrison 21e Ch 298]